Ed Abrahams has a message for Nancy Pelosi on HR 3. That’s the new bill in the house to reduce...
36:22
Karen Miga on the Next Era of Genomics
"Welcome to the era of T2T genomics,” tweeted UCSC’s Karen Miga on August 16th of this year....
25:49
September 2019 Review with Nathan and Laura: Same-Sex Genetics, Mosquitos, and Another DTC Scandal
After the summer break, Nathan and Laura, stir from their beach slumbers, to again offer their...
56:54
We Can See Tumor Heterogeneity. Now What? We Ask Cathy Smith, UCSF
Cathy Smith counts herself among the Gleevec Generation after the landmark targeted cancer...
29:39
We Knew about Tumor Heterogeneity, Now We Can See It: Cathy Smith of UCSF
Cathy Smith counts herself among the Gleevec Generation after the landmark targeted cancer...
29:54
Hallelujah! A Universal Flu Preventative and Therapy with Jeff Stein, Cidara
As another summer winds down, another flu season approaches. Yuuuk. When will we be able to...
23:13
John Cumbers on SynBioBeta 2019
Synthetic biology is experiencing a second renaissance and the place to be this October 1-3 is at...
40:10
Anya Prince on Our Current Vulnerability to Genetic Discrimination
Some Americans still resist genetic testing for fear they will be discriminated against by...
29:22
Do Long Reads Hold Answers for Alzheimer’s? with Mark Ebbert, Mayo
It’s the kind of plot that makes great science. There are genes that have been hiding in plain...
32:13
With Nanopore Sensing Beyond Sequencing: Ontera Takes 'Lab' to the Field
We’ve interviewed several CEOs over the years since the Theranos fiasco who avoided any mention...
25:04
Mark Chaisson on Two New Structural Variation Papers
If you’re not on the long read sequencing train, you’re not landing in the world of genomics. A...
41:30
Early Cancer Detection: Is This Company Ahead of Grail?
The great promise of liquid biopsy technology is in early cancer detection. That is, it's the...
31:59
June 2019 Review with Nathan and Laura: Gene Patents, Grail, Dr. Lynch
Nathan and Laura join Theral for our final review show before the summer break. Have you already...
42:49
Should a Genomic Screen Be Standard of Care? with Adam Buchanan, Geisinger
Those of us watching every shift in the level of adoption of genomic medicine have our eyes...
37:42
May 2019 Review with Nathan and Laura: Gene Therapies, DTC Shifts, Abortion and Gender
Our two reigning champions are back for a month packed with news. It’s Nathan Pearson of Root...
51:46
Toward the Human Pan Genome with Adam Phillippy, NHGRI
Storylines repeat each other in genomic science every decade or so. The human genome is...
35:11
Please! No Horoscopes on the Science Page: Laura Hercher Talks DTC Genetic Testing
"DTC is now too big of an arena to put everything in the same bucket.” This was a line from Laura...
49:14
Arcadia Biosciences Jujitsus Around GMO Resistance with GoodWheat and Better Cannabis
Today we're joined by Matt Plavan, President of Arcadia Specialty Genomics. The last time we...
28:51
April was a tough month for some genomics companies. The FBI raided the offices of uBiome and...
42:30
The Era of the Social Genome with Rodrigo Martinez, Veritas Genetics
Two years ago Veritas Genetics began offering whole genome sequencing for a thousand dollars. It...
49:20
Premium
Plus